[
  {
    "id": 1551,
    "name": "Indee Labs",
    "slug": "indee-labs",
    "former_names": [],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/ac1b20e8e540ce71927b19ed6cbc32f9956f9290.png",
    "website": "http://www.indeelabs.com",
    "all_locations": "Berkeley, CA, USA",
    "long_description": "Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.",
    "one_liner": "Enabling T cell immunotherapy discovery, development and manufacturing",
    "team_size": 5,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Drug Discovery and Delivery",
    "launched_at": 1481766629,
    "tags": [
      "Gene Therapy",
      "Microfluidics",
      "Cell Therapy"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Winter 2017",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Drug Discovery and Delivery"
    ],
    "regions": [
      "United States of America",
      "America / Canada",
      "Remote",
      "Partly Remote"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/indee-labs",
    "api": "https://yc-oss.github.io/api/batches/winter-2017/indee-labs.json"
  },
  {
    "id": 1746,
    "name": "Sixfold Bioscience",
    "slug": "sixfold-bioscience",
    "former_names": [
      "Sixfold Bioscience "
    ],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/b0f895aea5a3becf96dd016714d9e8aa78189e1b.png",
    "website": "https://www.sixfold.bio",
    "all_locations": "London, England, United Kingdom",
    "long_description": "Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression. \r\n\r\n",
    "one_liner": "Delivering RNA therapies.",
    "team_size": 27,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Drug Discovery and Delivery",
    "launched_at": 1509562895,
    "tags": [
      "Gene Therapy",
      "Nanomedicine",
      "Drug Delivery"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Winter 2018",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Drug Discovery and Delivery"
    ],
    "regions": [
      "United Kingdom",
      "Europe"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/sixfold-bioscience",
    "api": "https://yc-oss.github.io/api/batches/winter-2018/sixfold-bioscience.json"
  },
  {
    "id": 1939,
    "name": "64x Bio",
    "slug": "64x-bio",
    "former_names": [
      "64-X",
      "64-x"
    ],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/cfea1f5fda223a069c00cebbc1559d75a397a3f2.png",
    "website": "http://www.64xbio.com",
    "all_locations": "San Francisco, CA, USA",
    "long_description": "The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up.\r\n\r\nOur VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out. ",
    "one_liner": "Enabling next generation medicines. A comprehensive platform and…",
    "team_size": 25,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Industrial Bio",
    "launched_at": 1609711472,
    "tags": [
      "Gene Therapy",
      "Machine Learning"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Summer 2018",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Industrial Bio"
    ],
    "regions": [
      "United States of America",
      "America / Canada"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/64x-bio",
    "api": "https://yc-oss.github.io/api/batches/summer-2018/64x-bio.json"
  },
  {
    "id": 2021,
    "name": "Perception Biosystems",
    "slug": "perception-biosystems",
    "former_names": [
      "Reformer Therapeutics",
      "Perception Therapeutics"
    ],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/6725a216e652408a9448418d0067920052e512a2.png",
    "website": "https://www.perception.bio",
    "all_locations": "Palo Alto, CA, USA",
    "long_description": "Perception Biosystems is democratizing gene therapy through lab automation. Our mission is to accelerate the clinical translation of gene therapy by reinventing its manufacturing and development processes.\r\n\r\nWe're building a robotic lab in the SF Bay Area to translate the large facilities, labor, and regulatory requirements of current gene therapy factories into automated flexible manufacturing systems and code. This enables us to produce gene therapies for use in human clinical trials an order of magnitude faster and cheaper than the current solution – opening up thousands of rare disease targets otherwise thought too rare to pursue.",
    "one_liner": "Democratizing gene therapy by reinventing its manufacturing and…",
    "team_size": 2,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1527048485,
    "tags": [
      "Gene Therapy",
      "Biotech"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Summer 2018",
    "status": "Inactive",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "United States of America",
      "America / Canada"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/perception-biosystems",
    "api": "https://yc-oss.github.io/api/batches/summer-2018/perception-biosystems.json"
  },
  {
    "id": 2028,
    "name": "Rejuvenation Technologies Inc.",
    "slug": "rejuvenation-technologies-inc",
    "former_names": [
      "Rejuvenation Technologies Inc.",
      "Rejuvenation Technologies"
    ],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/8570f907143e200c57848585eb12a16271d3643f.png",
    "website": "https://www.rejuvenationtech.com/",
    "all_locations": "Mountain View, CA, USA",
    "long_description": "Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging.  We are advancing TERT mRNA-based therapies to the clinic.",
    "one_liner": "We extend telomeres to extend the human health span",
    "team_size": 2,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1527534662,
    "tags": [
      "Anti-Aging",
      "Gene Therapy",
      "Nanomedicine"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Summer 2018",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "United States of America",
      "America / Canada",
      "Remote",
      "Partly Remote"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/rejuvenation-technologies-inc",
    "api": "https://yc-oss.github.io/api/batches/summer-2018/rejuvenation-technologies-inc.json"
  },
  {
    "id": 22045,
    "name": "Nephrogen",
    "slug": "nephrogen",
    "former_names": [],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/ce4f8b04c9fefa06f0088d04f45b91af1e3fe8aa.png",
    "website": "http://www.nephrogenbiotech.com",
    "all_locations": "New York, NY, USA",
    "long_description": "Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases. Kidney disease affects 1 in 7 Americans (~50 million people), has no cure, and accounts for nearly 10% of the Medicare budget.",
    "one_liner": "Curative gene therapies for kidney diseases",
    "team_size": 1,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1660881251,
    "tags": [
      "Gene Therapy",
      "CRISPR",
      "Biotech"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Summer 2020",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "United States of America",
      "America / Canada"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/nephrogen",
    "api": "https://yc-oss.github.io/api/batches/summer-2020/nephrogen.json"
  },
  {
    "id": 23522,
    "name": "Nuntius Therapeutics",
    "slug": "nuntius-therapeutics",
    "former_names": [],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/490dca692522bd958768d197eafc08f9ea77c8fb.png",
    "website": "http://www.nuntiustx.com",
    "all_locations": "London, England, United Kingdom",
    "long_description": "",
    "one_liner": "Cell-specific genetic medicines",
    "team_size": 2,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1614621461,
    "tags": [
      "Gene Therapy",
      "Nanomedicine"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Winter 2021",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "United Kingdom",
      "Europe",
      "Remote",
      "Partly Remote"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/nuntius-therapeutics",
    "api": "https://yc-oss.github.io/api/batches/winter-2021/nuntius-therapeutics.json"
  },
  {
    "id": 25865,
    "name": "Andson Biotech",
    "slug": "andson-biotech",
    "former_names": [],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/8495f5832705b897265e143f4ea26b9403783542.png",
    "website": "http://www.andsonbiotech.com",
    "all_locations": "Atlanta, GA, USA",
    "long_description": "Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control. ",
    "one_liner": "Empowering Mass Spec for Biotech and Beyond",
    "team_size": 4,
    "industry": "Healthcare",
    "subindustry": "Healthcare",
    "launched_at": 1644435477,
    "tags": [
      "Gene Therapy",
      "Hard Tech",
      "Biotech",
      "Healthcare",
      "Therapeutics"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": true,
    "nonprofit": false,
    "batch": "Winter 2022",
    "status": "Active",
    "industries": [
      "Healthcare"
    ],
    "regions": [
      "United States of America",
      "America / Canada"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/andson-biotech",
    "api": "https://yc-oss.github.io/api/batches/winter-2022/andson-biotech.json"
  },
  {
    "id": 26311,
    "name": "WhiteLab Genomics",
    "slug": "whitelab-genomics",
    "former_names": [],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/ba69864f65b85fda9f05c3280bc3b39f42500013.png",
    "website": "https://whitelabgx.com",
    "all_locations": "Paris, Île-de-France, France; Boston, MA, USA",
    "long_description": "We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.",
    "one_liner": "Unleashing the potential of DNA and RNA based therapies using AI",
    "team_size": 40,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Drug Discovery and Delivery",
    "launched_at": 1644584538,
    "tags": [
      "Artificial Intelligence",
      "Gene Therapy",
      "Cell Therapy",
      "Genomics"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Winter 2022",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Drug Discovery and Delivery"
    ],
    "regions": [
      "France",
      "United States of America",
      "Europe",
      "America / Canada",
      "Remote",
      "Partly Remote"
    ],
    "stage": "Growth",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/whitelab-genomics",
    "api": "https://yc-oss.github.io/api/batches/winter-2022/whitelab-genomics.json"
  },
  {
    "id": 28205,
    "name": "Modulari-T",
    "slug": "modulari-t",
    "former_names": [
      "Modulari-T Biosciences"
    ],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/cdfde836f1d168c7ec0299ab6b4daf90d112f929.png",
    "website": "https://modularit.bio",
    "all_locations": "Montreal, QC, Canada; San Francisco, CA, USA",
    "long_description": "Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise.\r\n\r\nModulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue.\r\n\r\nModulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.",
    "one_liner": "We teach your immune system to attack and cure cancer",
    "team_size": 4,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1675126815,
    "tags": [
      "Gene Therapy",
      "Cell Therapy",
      "Synthetic Biology",
      "Biotech",
      "Oncology"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": true,
    "nonprofit": false,
    "batch": "Winter 2023",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "Canada",
      "United States of America",
      "America / Canada"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/modulari-t",
    "api": "https://yc-oss.github.io/api/batches/winter-2023/modulari-t.json"
  },
  {
    "id": 29714,
    "name": "Kopra Bio",
    "slug": "kopra-bio",
    "former_names": [
      "GlioTx"
    ],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/acdb0c2a3124d9e5717a63d0231af9b6f7447919.png",
    "website": "https://kopra.bio",
    "all_locations": "San Francisco, CA, USA",
    "long_description": "Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.",
    "one_liner": "Genetically engineered viruses that teach your immune system to kill…",
    "team_size": 2,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1724130421,
    "tags": [
      "Gene Therapy",
      "Synthetic Biology",
      "Biotech",
      "Therapeutics",
      "Oncology"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Summer 2024",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "United States of America",
      "America / Canada",
      "Remote",
      "Partly Remote"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/kopra-bio",
    "api": "https://yc-oss.github.io/api/batches/summer-2024/kopra-bio.json"
  },
  {
    "id": 29959,
    "name": "Uncommon Therapeutics",
    "slug": "uncommon-therapeutics",
    "former_names": [],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/791a2a1e71f62bafa47311d3711d9cab4712eea4.png",
    "website": "https://uncommontherapeutics.com",
    "all_locations": "San Francisco, CA, USA",
    "long_description": "Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.",
    "one_liner": "A Disease Focused Biotech, Building Multiple Billion Dollar Drugs",
    "team_size": 2,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1740166772,
    "tags": [
      "Gene Therapy",
      "CRISPR",
      "Biotechnology"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Winter 2025",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "United States of America",
      "America / Canada",
      "Remote",
      "Partly Remote"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/uncommon-therapeutics",
    "api": "https://yc-oss.github.io/api/batches/winter-2025/uncommon-therapeutics.json"
  }
]
